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Solid-State NMR Studies of the Effects of
Pharmaceutical Processing on Relaxation
Dynamics and Implications to Solid-State
Drug Stability
Lactose and acetylsalicylic acid (aspirin) were subjected to various
formulation and processing conditions, and the effects upon CPMAS
NMR spectra and relaxation dynamics were investigated.
Relaxation dynamics can provide valuable insight into physicochemical
properties and stability of bulk drugs and solid-state formulations
Particle size reduction and introduction of highly mobile domains (i.e.
crystal defect sites and amorphous material) results in much faster
overall 1H T1 relaxation for the entire sample
Detection of amorphous material is critical to the pharmaceutical
industry, as it can have drastic effects on formulation stability, efficacy,
and safety
Effects of processing on relaxation dynamics may provide insight into
the long-term stability of formulations
Introduction
Changes in Relaxation Dynamics
Upon Processing
Lactose chosen due to its
wide usage as an excipient
Rigid crystalline system with
no natural relaxation sinks
(methyl groups)
Large changes in T1 observed
with little change in spectra
for compressed and 2-minute
cryoground samples
Cryogrinding for 30 minutes
gave lower T1 than pure
amorphous lactose
Model of Processing Effects
 Region A represents the part of the sample that relaxes the slowest, or the
crystalline part of the sample
 Region B represents the parts of the sample where mobility is greatest, for
example the surface of a crystal, defect sites, or amorphous regions
 During grinding Region A gets broken into small pieces, and Region B gets
bigger because crystal defects and amorphous material are created under
the stress of grinding
 This means that energy can be transferred more efficiently from Region A
to Region B and the entire sample can relax much faster
 Through-space dipolar
interaction enabling energy
transfer between like spins
 Spin-lattice relaxation
dominated by the fastest
relaxing species present
 Magnetization is transferred
from slow-relaxing domains to
fast-relaxing domains
 With efficient magnetization
transfer, a common T1 is
observed for entire sample
Adapted from Stejskal, E.O. and Memory, J.D. High Resolution NMR in
the Solid State. ©1994 Oxford University Press, Inc. p. 106.
Spin Diffusion
Relaxation and Stability
What does relaxation have to do with drug stability?
 Relaxation is directly correlated with sample mobility, and mobility is
correlated with reactivity, so measuring relaxation times may tell us
which drug formulations are going to be least stable over time
More mobile drugs are more likely to react, because it takes motion
and energy for two molecules to encounter each other and undergo a
chemical reaction
 These degradation reactions occur over time, and the time it takes for
10% of a drug to degrade is its viable shelf life
 The FDA requires marketed drug products to have at least a two-year





 Bulk (unprocessed) aspirin has a
relaxation time of 57 s
 As was the case with lactose,
cryogrinding reduced T1 times of
aspirin, with longer grinding times
giving lower relaxation times
 All five spectra are nearly identical,
indicating that aspirin does not become
amorphous upon cryogrinding
 Amorphous aspirin would be
manifested as broad peaks underlying
the sharp crystalline peaks
 The T1 reduction is likely entirely due
to reducing the particle size and
introducing many crystal defect sites
Aspirin Stability
 On the left are HPLC chromatograms for bulk aspirin and aspirin immediately after
cryogrinding
 The single aspirin peak indicates that no degradation occurred during cryogrinding
 On the right are aspirin HPLC chromatograms run after 3 days in a stability chamber at
75 °C and 85% relative humidity
 The salicylic acid peak
increases in samples
ground for longer
times, and the sample
ground for 60 minutes
has no aspirin
remaining at all
 This shows that the
samples ground for
longer periods of time
are much less stable
than unprocessed
aspirin
Day 0 Day 3 (75°C/85%RH)
Aspirin and Starch Mixtures
Blend
1H T1= 57 s
Cryoground
1H T1= 7.6 s
 50:50 physical mixture of aspirin and
Starch 1500 was prepared and
cryoground for 30 minutes
 Unprocessed blend of aspirin and starch
used as control
 1H T1 of cryoground material significantly
less than control
 DSC showed melting point of
cryoground material (133.97 °C) less
than that of control (137.02 °C)
 Water vapor sorption at 90% RH
showed weight gain of 9.1% for
cryoground material, while control
gained 6.25%
 All data indicates faster degradation of
cryoground material
Degradation of Aspirin Mixed
With Starch
 The aspirin/starch blend and cryoground material were stored at 75 °C
and 55% RH
Aspirin Peak Salicylic Acid Peak 
t=0 99.93 0.07
t=1 week 81.44 18.56
t=2 weeks 71.87 28.13
Aspirin Peak Salicylic Acid Peak 
t=0 99.84 0.16
t=1 week 59.89 40.11
t=2 weeks 3.88 96.12
% Area
50:50 Aspirin:Starch Blend (Control) 
50:50 Aspirin:Starch Cryoground 30 min. 
% Area
 Samples were removed and
analyzed by HPLC at various
time points
 Hydrolysis to salicylic acid was
monitored, and found to
occur at a faster rate in the
cryoground material
compared to the control
 These stability results
correlate nicely with the
relaxation times, melting
points, and hygroscopicity of
each sample
NMR Spectra of 13C-Labeled Aspirin and
Natural Abundance Aspirin
Monitoring Degradation of a Minor
Component Using Solid-State NMR
 Initial Samples  7 days at 70 ºC, 50% RH
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13C-Labeled Aspirin Lyophilized with HPMC
and Mixed With Unlabeled Aspirin
6 mg 13C-Aspirin + 100 mg HPMC
(Lyophilized Together)
6 mg 13C-Aspirin + 100 mg HPMC
(Freeze Dried Together)
+
294 mg Unlabeled Aspirin




Degradation of Amorphous Aspirin
10 mg 13C-Salicylic Acid + 
100 mg HPMC (Freeze Dried)
10 mg 13C-Aspirin + 
100 mg HPMC (Freeze Dried)
10 mg 13C-Aspirin + 
100 mg HPMC (Freeze Dried)
1 Day at
70 ºC, 50% RH
10 mg 13C-Aspirin + 
100 mg HPMC (Freeze Dried)
6 Days at





A New Form of Aspirin?
 Evidence from Solid-State NMR
Aspirin from two suppliers
was studied using 13C
CPMAS NMR spectroscopy






Changes in 1H T1
 See Diana Sperger’s poster
for more information
Degradation of Lyophilized Aspirin
Aldrich bulk aspirin and
lyophilized aspirin submitted




 Mobile phase - MeOH/H2O
gradient
 Column - Symmetry C18
5 µm 4.6 x 250 mm
 UV Detection - 235 nm
Results show that lyophilized
material degrades at a faster
rate
Conclusions and Future Work
Small amounts of highly mobile domains can have a
significant impact on overall sample relaxation times
Amorphous aspirin dispersed in HPMC degrades much
faster than pure crystalline aspirin
Cryogrinding bulk aspirin does not appear to produce any
significant changes in solid-state NMR spectra, however
relaxation times were reduced
Lyophilizing pure aspirin may result in a new metastable
crystalline form of aspirin
Future studies will attempt to correlate relaxation times
with long term stability studies of processed aspirin
formulations
